DANA-FARBER CANCER INSTITUTE INC.;PETER MACCALLUM CANCER INSTITUTE
发明人:
申请号：
IL25821218
公开号：
IL258212D0
申请日:
2018.03.19
申请国别(地区):
IL
年份:
2018
代理人:
摘要：
The present disclosure provides combination therapy of a bromodomain inhibitor and an immune modulator (e.g., an immune check point inhibitor). The combination of the bromodomain inhibitor and the immune modulator may be useful in treating or preventing cancer in a subject. In certain embodiments, the subject has an intact immune system. The combination of the bromodomain inhibitor and the immune modulator is expected to be synergistic.
